MessageWell, thanks a lot Mr. FS, I really appreciated it. 

  ----- Original Message ----- 
  From: Frederick Schubert 
  To: obrolan-bandar@yahoogroups.com 
  Sent: Tuesday, December 05, 2006 3:37 PM
  Subject: Re: [obrolan-bandar] CMNP lari terbirit-birit



  fyi, please see cmnp from merrill....


  "Eddy S. Purnomo" <[EMAIL PROTECTED]> wrote: 
    CMNP busyet dah. Itu target CnH di 1.260 ditabrak terus. Sesuai dengan 
bisnisnya Jalan Tol.




------------------------------------------------------------------------------
  Everyone is raving about the all-new Yahoo! Mail beta.

   


------------------------------------------------------------------------------


  From: Mathieson, Rosalind [EMAIL PROTECTED]
  Sent: Tuesday, December 05, 2006 2:34 PM
  To: Kyne, Phelim; Pranasidhi, Edhi; Sentana, I-Made
  Subject: FW: CMNP IJ: Citra Marga Nusaphala Persada: Several potential 
catalysts - BUY - Indonesia - 15pp


  -----Original Message-----
  From: Li, Robert 
  Sent: Tuesday, December 05, 2006 3:08 PM
  To: Mathieson, Rosalind
  Subject: FW: CMNP IJ: Citra Marga Nusaphala Persada: Several potential 
catalysts - BUY - Indonesia - 15pp





  ----------

  From:   ML-Verdi Budiman[SMTP:[EMAIL PROTECTED] 
  Sent: Tuesday, December 05, 2006 3:07:44 PM 
  To:        Li, Robert 
  Subject:      CMNP IJ: Citra Marga Nusaphala Persada: Several potential 
catalysts - BUY - Indonesia - 15pp 
  Auto forwarded by a Rule


            
       Citra Marga Nusaphala Persada  
       Initial Opinion BUY  
       Several potential catalysts, a new Buy     
       
        Link to full report including important disclosures*     
        http://rsch1.ml.com/9093/24013/ds/59472849.PDF     

        Largest private urban toll road operator in Indonesia
       
        CMNP operates 30km segments of the Jakarta intra urban toll road 
system, with the 12km Surabaya Eastern ring road system under construction. It 
recently won a licence for the 23km long Depok-Antasari tollroad. 

       
        Undervalued
       
        Our DCF estimate of about Rp2,000 forms the basis of our PO. It does 
not include any value from its stakes in Citra Metro Manila Tollways 
Corporation and Bogor ring road. Its high 2007 P/E hides the strong recurring 
cash flow, the new legal power to periodically raise tariffs, and the value of 
its new toll roads. 

       
        Toll tariff increase in 2H07 could be substantial
       
        CMNP is scheduled to increase its toll tariffs between June and August 
2007, based on 2005 and 2006 CPI. A 15-20% increase in toll tariffs should 
underpin 2008 earnings growth and act as a catalyst for the share price, in our 
view. 

       
        Surabaya project may start contributing to profits in 2H07
       
        After being stagnant for years, the management has re-intensified the 
build-out of Surabaya eastern ring road. It has an ambitious internal target to 
operate a part of the tollroad in March 2007 and be fully operational by June 
2007. 

       
        Jasa Marga IPO could present new possibilities
       
        First, the IPO plan of this state toll road company in 1H07 may bring 
market attention back to CMNP. Second, Jasa Marga owns a 17.8% stake in CMNP 
that it may consider selling as part of the IPO process. The sale could 
bring-in new possibilities regarding CMNP's ownership structure and stock 
trading liquidity. 

       
        A glimmer of restructuring hope for the Manila Skyway
       
        Citra Metro Manila Tollways Corporation has an excessive debt burden 
that has not been restructured since the Asian currency crisis. CMNP management 
seems hopeful of a restructuring progress in 2007. 
       

  To reply to Verdi Budiman directly, click here or call +62 21 515 8588

        * Read the research report, available through the link above, for 
complete information including important disclosures and analyst 
certification(s). Reports can be saved to your local drive in .pdf format. 
Merrill Lynch URLs are active for six months from the date that such report is 
published. There may be more recent information available. Please visit one of 
the electronic venues that carry Merrill Lynch research or contact your Merrill 
Lynch representative for further information. 
       
       
       
              iQanalyticsSM
              Merrill Lynch's iQanalyticsSM capabilities include a defined 
valuation methodology, the iQdatabase®, which draws on over 2,650 company 
models prepared by our Fundamental Equity analysts globally, and a series of 
proprietary software tools. Information is presented in a consistent format as 
explained in our iQmethodSM report. Using the iQanalytics platform, Merrill 
Lynch analysts and clients can select and compare financial metrics across 
sectors and regions under our coverage on a consistent basis, with a focus on 
recent and forecast company performance and valuation.

              The key features of iQmethodSM are: .   A consistently 
structured, detailed and transparent methodology, with data sourced directly 
from our analysts' models. 
                    .   Guidelines to maximize the effectiveness of the 
comparative valuation process, and to identify some common pitfalls. 

              Click here for the iQmethod report

              iQdatabase®
              The iQdatabase® is Merrill Lynch Global Securities Research & 
Economics Group's globally integrated real time research database that is 
sourced directly from our Fundamental Equity analysts' earnings models, and 
includes forecast as well as historical data for income statements, balance 
sheets and cash flow statements for companies covered by Merrill Lynch.

              For more information on what iQanalytics can do for you, contact 
your Merrill Lynch representative.
              iQanalytics and, iQmethod are service marks of Merrill Lynch & 
Co., Inc. iQdatabase® is a registered service mark of Merrill Lynch & Co., Inc. 
To receive ML Research emails in plain text format, click here 

              If you would like to stop or modify the delivery of Research via 
Email, click here or contact Research Publications:

              The Americas:
              +1 888 734 1391 or +1 212 449 9765

              Europe, Middle East & Africa:
              +44 20 7996 2526 or +44 20 7996 4444

              Asia Pacific (ex-Japan) & Australasia:
              +852 2536 3036

              Japan:
              +813 6225 7677 or +813 6225 6264
             
              Publication: 285337-10567631.pdf
              Recipient: Mr. Robert Li 
       
   

Kirim email ke